Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Zhang

Showing results (351-360 of 373) with videos related to

Pageof 38
Sort By:
Journal of Medicinal Chemistry|October 19, 2022
Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A VirusesSaad Alqarni, Laura Cooper, Jazmin Galvan Achi, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trialHangcheng Xu, Yan Wang, Qiang Sa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical TrialQiao Li, Xiuwen Guan, Shanshan Chen, et al.
Gland Surgery|February 26, 2021
Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective studyWei Zhang, Bai-Lin Zhang, Jian-Jun He, et al.
BMC Cancer|August 24, 2011
A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in ChinaJing Li, Bao-Ning Zhang, Jin-Hu Fan, et al.
International Journal of Surgery (London, England)|August 22, 2025
Histological response and hepatic steatosis changes in nonalcoholic fatty liver disease after bariatric surgeryMengyi Li, Na Zeng, Lu Yang, et al.
JAMA Oncology|August 26, 2021
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical TrialYing Fan, Tao Sun, Zhimin Shao, et al.
Chinese Medical Journal|August 1, 2023
Management and outcomes of gastric leak after sleeve gastrectomy: results from the 2010-2020 national registryMengyi Li, Na Zeng, Yang Liu, et al.
Cancer Biology & Medicine|May 26, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNAAnjie Zhu, Peng Yuan, Nanlin Hu, et al.
Practical Radiation Oncology|March 29, 2014
Epidemiologic study of compliance to postmastectomy radiation therapy guidelines in breast cancer patients in China between 1999 and 2008Shu-Lian Wang, Ye-Xiong Li, Bao-Ning Zhang, et al.
Pageof 38

Showing results (351-360 of 373) with videos related to

Sort By:
Pageof 38
Journal of Medicinal Chemistry|October 19, 2022
Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A VirusesSaad Alqarni, Laura Cooper, Jazmin Galvan Achi, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trialHangcheng Xu, Yan Wang, Qiang Sa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical TrialQiao Li, Xiuwen Guan, Shanshan Chen, et al.
Gland Surgery|February 26, 2021
Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective studyWei Zhang, Bai-Lin Zhang, Jian-Jun He, et al.
BMC Cancer|August 24, 2011
A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in ChinaJing Li, Bao-Ning Zhang, Jin-Hu Fan, et al.
International Journal of Surgery (London, England)|August 22, 2025
Histological response and hepatic steatosis changes in nonalcoholic fatty liver disease after bariatric surgeryMengyi Li, Na Zeng, Lu Yang, et al.
JAMA Oncology|August 26, 2021
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical TrialYing Fan, Tao Sun, Zhimin Shao, et al.
Chinese Medical Journal|August 1, 2023
Management and outcomes of gastric leak after sleeve gastrectomy: results from the 2010-2020 national registryMengyi Li, Na Zeng, Yang Liu, et al.
Cancer Biology & Medicine|May 26, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNAAnjie Zhu, Peng Yuan, Nanlin Hu, et al.
Practical Radiation Oncology|March 29, 2014
Epidemiologic study of compliance to postmastectomy radiation therapy guidelines in breast cancer patients in China between 1999 and 2008Shu-Lian Wang, Ye-Xiong Li, Bao-Ning Zhang, et al.
Pageof 38